BioXcel Therapeutics Inc. Common Stock (BTAI)

About BTAI

BioXcel Therapeutics, Inc., together with its subsidiary, OnkosXcel Therapeutics LLC, operates as a biopharmaceutical company that utilizes artificial intelligence approaches to develop medicines in neuroscience and immuno-oncology in the United States. The company IGALMI, a sublingual film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults. It also develops its n…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

29

Website

www.bioxceltherapeutics.com/

Fundamentals

1-day range

$0.79$0.8637

Market cap

$25.63M

P/E (trailing)

—

P/E (forward)

-0.53

EPS (trailing)

$-5.74

Dividend yield

—

Beta

0.25

Avg. volume

989.5K

Forecasts

4 analyst ratings

BioXcel Therapeutics Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• BTAI

  BioXcel Therapeutics Inc. Common Stock

  $0.1824

  ▼ 74.63%
  Market cap $25.63MP/E —
  $0.1569$4.29
• AYTU

  Aytu BioPharma Inc. Common Stock

  $2.27

  ▲ 1.34%
  Market cap $25.01MP/E —
  $1.65$3.07
• LGVN

  Longeveron Inc. Class A Common Stock

  $6.72

  ▼ 1.47%
  Market cap $24.44MP/E —
  $4.75$12.3
• TXMD

  TherapeuticsMD Inc. Common Stock

  $2.22

  ▼ 0.89%
  Market cap $24.19MP/E 135.01
  $0.99$2.95
• ABVC

  ABVC BioPharma Inc. Common Stock

  $0.8251

  ▲ 3.66%
  Market cap $27.09MP/E —
  $0.7069$3.4
• IGC

  IGC Pharma Inc. Common Stock

  $0.3086

  ▼ 6.48%
  Market cap $23.94MP/E —
  $0.235$0.47
• BRNS

  Barinthus Biotherapeutics plc American Depositary Shares

  $0.7464

  ▲ 2.11%
  Market cap $23.08MP/E —
  $0.512$1.83

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• Friday's session: top gainers and losers
  ChartMill · 8/28/2026
• Which stocks are experiencing notable movement on Friday?
  ChartMill · 8/28/2026
• Deal Dispatch: Carets Corp Explores Strategic Alternatives, nVent Electric Buys Maverick Power for $1.75 Billion, BioXcel Bankruptcy
  Benzinga · 8/28/2026
• BioXcel Stock Plunges: Chapter 11 Filing Triggers Teva Stalking Horse Bid
  benzinga · 8/28/2026
• Gapping stocks in Friday's session
  ChartMill · 8/28/2026
• 12 Health Care Stocks Moving In Friday's Intraday Session
  Benzinga · 8/28/2026
• Stay updated with the stocks that are on the move in today's pre-market session.
  ChartMill · 8/28/2026
• BioXcel Stock Plunges: Chapter 11 Filing Triggers Teva Stalking Horse Bid
  Benzinga · 8/28/2026
• Dow Gains 100 Points; Chicago PMI Falls In August
  Benzinga · 8/28/2026

• Atkins Susan E. · August 12, 2026 · Grant

  17.0K
• Richard I. Steinhart · June 15, 2026 · Option Exercise

  35
• Frank Yocca · May 20, 2026 · Sale

  6.8K @ $1.09
• Javier Rodriguez · May 20, 2026 · Sale

  6.6K @ $1.08
• Vimal Mehta · May 20, 2026 · Sale

  19.4K @ $1.09
• Richard I. Steinhart · May 20, 2026 · Sale

  6.8K @ $1.09
• Frank Yocca · May 4, 2026 · Option Exercise

  17.5K
• Javier Rodriguez · May 4, 2026 · Option Exercise

  17.5K
• Vimal Mehta · May 4, 2026 · Option Exercise

  49.8K
• Richard I. Steinhart · May 4, 2026 · Option Exercise

  17.5K
• Vimal Mehta · May 1, 2026 · Option Exercise

  18.0K
• Frank Yocca · May 1, 2026 · Option Exercise

  9.0K
• Javier Rodriguez · May 1, 2026 · Option Exercise

  9.0K
• Richard I. Steinhart · May 1, 2026 · Option Exercise

  9.0K
• Vimal Mehta · March 15, 2026 · Option Exercise

  219

Institutional Ownership

March 31, 2026

Total shares held

5.35M

Total value held

$7.16M

Institutional holders

36